| 5'-O-(4,4'-DIMETHOXYTRITYL)-N6-METHYL-2'-DEOXYADENOSINE, 3'-[(2-CYANOETHYL)-(N,N-DIISOPROPYL)]PHOSPHORAMIDITE |
5'-O-[二(4-甲氧基苯基)苯基甲基]-2'-脱氧-N-甲基腺苷 3'-[2-氰基乙基二(异丙基)亚磷酰胺] |
105931-58-6 |
| (S)-2-(((9H-fluoren-9-yl)Methoxy)carbonylaMino)-3-(1-Methyl-1H-indol-3-yl)propanoic acid |
FMOC-TRP(1-ME)-OH |
1334509-86-2 |
| CUDC-101 |
7-[[4-(3-乙炔基苯基氨基)-7-甲氧基喹唑啉-6-基]氧基]-N-羟基庚酰胺 |
1012054-59-9 |
| CRA-02478 |
PCI-24781 |
783355-60-2 |
| FMOC-L-CYCPENTALA-OH |
FMOC-L-环戊基丙氨酸 |
371770-32-0 |
| H-HIS-PHE-OH |
H-HIS-PHE-OH |
16874-81-0 |
| H-HIS-ASP-OH |
H-HIS-ASP-OH |
41658-60-0 |
| H-GLY-GLY-PHE-OH |
甘氨酰甘氨酰-L-苯丙氨酸 |
6234-26-0 |
| H-ASP-ASP-OH |
H-ASP-ASP-OH |
58471-53-7 |
| D-Tryptophan, N-[N-[(1,1-dimethylethoxy)carbonyl]-2-methylalanyl]- |
N-[N-[(1,1-二甲基乙氧基)羰基]- 2-甲基丙氨酰]-D-色氨酸 |
159634-94-3 |
| ETHYL-2-OXIMINOOXAMATE, 97% |
2-肟基草氨酸乙酯 |
10489-74-4 |
| DL-2-AMINO-4-PENTENOIC ACID |
DL-2-氨基-4-戊烯酸 |
7685-44-1 |
| L-Propargylglycine |
L-炔丙基甘氨酸 |
23235-01-0 |
| PI3K/HDAC Inhibitor |
CUDC-907 |
1339928-25-4 |
| ACY-1215 |
ACY1215 |
1316214-52-4 |
| N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-cytidine phosphoramidite |
N4-苯甲酰基-5'-O-DMT-2'-氟-脱氧胞苷-3'-氰乙氧基亚磷酰胺 |
161442-19-9 |
| FMOC-ASP(OMPE)-OH |
芴甲氧羰基-(3-甲基戊基酯)-天冬氨酸 |
180675-08-5 |
| N-Boc-PEG6-alcohol |
六聚乙二醇-叔丁氧羰基 |
331242-61-6 |
| Amino-PEG5-t-butyl ester |
氨基-四聚乙二醇-丙酸叔丁酯 |
1446282-18-3 |
| FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH |
(4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,5-二氧代-5-[(三苯基甲基)氨基]戊基]-2,2,5-三甲基-4-恶唑烷羧酸 |
1572725-72-4 |
QQ
